Actinium Pharmaceuticals, Inc
Actinium Pharmaceuticals, Inc., based in New York, NY, is a biopharmaceutical company focused on developing targeted radiotherapies for patients with unmet medical needs. Their pipeline includes Antibody Radiation Conjugates for targeted conditioning and combination therapies, with a particular focus on CD33 targeting for AML treatment.
With positive top-line results from their pivotal Phase 3 SIERRA Trial, Actinium is at the forefront of developing innovative therapies such as Iomab-B and Actimab-A to provide effective and personalized treatment options for patients. Their commitment to advancing targeted conditioning and radiotherapy technologies underscores their dedication to improving outcomes for individuals facing challenging medical conditions.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.
Partial Data by Foursquare.